Development of an isoform-specific gene suppression system: The study of the human Pax-5B transcriptional element

Nucleic Acids Research

Volumn 36, Issue 14, 2008, Pages 4609-4620

  Robichaud, Gilles A ^a,b,c   Perreault, Jean Pierre ^a   Ouellette, Rodney J ^b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b ATLANTIC CANCER RESEARCH INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONCTON   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CELL SURFACE PROTEIN; MESSENGER RNA; RIBOZYME; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PAX5B; VIRUS ENZYME;

APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL FATE; CELL LEVEL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; GENETIC TRANSFECTION; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA CLEAVAGE; RNA TRANSCRIPTION;

ANTIGENS, CD19; APOPTOSIS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CELL LINE; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HEPATITIS DELTA VIRUS; HUMANS; PROTEIN ISOFORMS; RNA STABILITY; RNA, CATALYTIC; RNA, MESSENGER; TRANSCRIPTION FACTORS;

HEPATITIS DELTA VIRUS;

EID: 49249116787     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn432     Document Type: Article

References (47)

1. Chi,N. and Epstein,J.A. (2002) Getting your Pax straight: Pax proteins in development and disease. Trends Genet., 18, 41-47.
2. Robson,E.J., He,S.J. and Eccles,M.R. (2006) A PANorama of PAX genes in cancer and development. Nat. Rev. Cancer, 6, 52-62.
3. Maulbecker,C.C. and Gruss,P (1993) The oncogenic potential of Pax genes. EMBO J., 12, 2361-2367.
4. Adams,B., Dorfler,P., Aguzzi.A., Kozmik,Z., Urbanek.P., Maurer-Fogy, I. and Busslinger,M. (1992) Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev., 6, 1589-1607.
5. Hagman,J., Wheat,W., Fitzsimmons,D., Hodsdon,W., Negri,J. and Dizon,F. (2000) Pax-5, BSAP: Regulator of specific gene expression and differentiation in B lymphocytes. Curr. Top. Microbiol. Immunol., 245, 169-194.
6. Rolink,A.G., Schaniel,C., Busslinger,M., Nutt,S.L. and Melchers,F. (2000) Fidelity and infidelity in commitment to B-lymphocyte lineage development. Immunol. Rev., 175, 104-111.
7. Kozmik,Z., Wang,S., Dorfler,P., Adams,B. and Busslinger,M. (1992) The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell Biol., 12, 2662-2672.
8. Zwollo,P. and Desiderio,S. (1994) Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. J. Biol. Chem., 269, 15310-15317.
9. Nutt,S.L., Heavey,B., Rolink,A.G. and Busslinger,M. (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 401, 556-562.
10. Wallin,J.J., Rinkenberger,J.L., Rao,S., Gackstetter,E.R., Koshland,M.E. and Zwollo,P. (1999) B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development. J. Biol. Chem. 274, 15959-15965.
11. Busslinger,M., Klix,N., Pfeffer,P., Graninger,P.G. and Kozmik,Z. (1996) Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl Acad. Sci. USA, 93, 6129-6134.
12. Liu,M.L., Rahman,M., Hirabayashi,Y. and Sasaki,T. (2002) Sequence analysis of 5′-flanking region of human pax-5 gene exon 1B. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 10, 100-103.
13. Asif-Ullah,M., Levesque,M., Robichaud,G. and Perreault,J.P. (2007) Development of ribozyme-based gene-inactivations; the example of the hepatitis delta-virus ribozyme. Curr. Gene Ther., 7, 205-216.
14. Sedz,C.A., Holko,M., de Veer,M.J., Silverman,R.H. and Williams,B.R. (2003) Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol., 5, 834-839.
15. Svoboda,P. (2007) Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr. Opin. Mol. Ther., 9, 248-257.
16. Wu,H.N.. Lin,Y.J., Lin,F.P., Makino,S., Chang,M.F. and Lai,M.M. (1989) Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc. Natl Acad. Sci. USA, 86, 1831-1835.
17. Peracchi,A. (2094) Prospects for antiviral ribozymes and deoxyripozymes. Rev. Med. Virol., 14, 47-64.
18. Bergeron,L.J. and Perreault,J.P. (2005) Target-dependent on/off switch increases ribozyme fidelity. Nucleic Acids Res., 33, 1240-1248.
19. Bergeron,L.J., Reymond,C. and Perreault,J.P. (2005) Functional characterization of the SOFA delta ribozyme. RNA, 11, 1858-1868.
20. Robichaud,G.A., Nardini,M., Laflamme,M., Cuperlovic-Culf,M. and Ouellette,R.J. (2004) Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. J. Biol. Chem., 279, 49956-49963.
21. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
22. Leclerc,G.J., Leclerc,G.M. and Barredo,J.C. (2002) Real-time RT-PCR analysis of mRNA decay: Half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines. Cancer Cell Int., 2, 1.
23. Bergeron,L.J., Ouellet,J. and Perreault,J.P. (2003) Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme. Curr. Med. Chem. 10, 2589-2597.
24. Lucier,J.F., Bergeron,L.J., Briere,F.P., Ouellette,R., Elela,S.A. and Perreault,J.P. (2006) RiboSubstrates: A web application addressing the cleavage specificities of ribozymes in designated genomes. BMC Bioinformatics, 7, 480.
25. Ulivieri,C. and Baldari,C.T. (2005) The BCR signalosome: Where cell fate is decided. J. Biol. Regul. Homeost. Agents, 19, 1-16.
26. Tedder,T.F., Poe,J.C., Fujimoto,M., Haas,K.M. and Sato,S. (2005) The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: Systemic sclerosis as a model system. Curr. Dir. Autoimmun., 8, 55-90.
27. Hirokawa,S., Sato,H., Kato,I. and Kudo,A. (2003) BBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells. Eur. J. Immunol., 33, 1824-1829.
28. Rahman,M., Hirabayashi,Y., Ishii,T., Watanabe,M., Maolin,L. and Sasaki,T. (2001) Prednisolone sodium succinate down-regulates BSAP/Pax5 and causes a growth arrest in the Nalm6 pre-B cell line. Tohoku J. Exp. Med., 193, 237-244.
29. Qiu,G. and Stavnezer,J. (1998) Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the 1.29 mu B cell line. J. Immunol., 161, 2906-2918.
30. Hamada,T., Yonetani,N., Ueda,C., Maesako,Y., Akasaka,H., Akasaka,T., Ohno,H., Kawakami,K., Amakawa,R. and Okuma,M. (1998) Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell- noni-Hodgkin's lymphoma. Br. J. Haematol., 102, 691-700.
31. Baumann Kubetzko, F.B., Di Paolo,C., Maag,C., Meier,R., Schafer,B.W., Betts,D.R., Stahel,R.A. and Himmelmann,A. (2004) The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis, 25, 1839-1846.
32. Max,E.E., Wakatsuki,Y., Neurath,M.F. and Strober,W. (1995) The role of BSAP in immunoglobulin isotype switching and B-cell proliferation. Curr. Top. Microbiol. Immunol., 194, 449-458.
33. Kovac,C.R., Emelyanov,A., Singh,M., Ashouian,N. and Birshtein,B.K. (2000) BSAP (Pax5)-importin alpha 1 (Rch1) interaction identifies a nuclear localization sequence. J. Biol. Chem., 275, 16752-16757.
34. Zwollo,P., Arrieta,H., Ede,K., Molinder,K., Desiderio,S. and Pollock,R. (1997) The Pax-5 gene is alternatively spliced during B-cell development. J. Biol. Chem., 272, 10160-10168.
35. Lowen,M., Scott,G. and Zwollo,P. (2001) Functional analyses of two alternative isoforms of the transcription factor Pax-5. J. Biol. Chem., 276, 42565-42574.
36. Pridans,C., Holmes,M.L., Polli,M., Wettenhall,J.M., Dakic,A., Corcoran,L.M., Smyth,G.K. and Nutt,S.L. (2008) Identification of Pax5 target genes in early B cell differentiation. J. Immunol., 180 1719-1728.
37. Akashi,H., Matsumoto,S. and Taira,K. (2005) Gene discovery by ribozyme and siRNA libraries. Nat. Rev. Mol. Cell Biol., 6, 413-422.
38. Nutt,S.L., Morrison,A.M., Dorfler,P., Rolink,A. and Busslinger,M. (1998) Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J., 17, 2319-2333.
39. Fujimoto,M., Fujimoto,Y., Poe,J.C., Jansen,P.J., Lowell,C.A., DeFranco,A.L. and Tedder,T.F. (2000) CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity, 13, 47-57.
40. Fearon,D.T. and Carroll,M.C. (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol., 18, 393-422.
41. Mahmoud,M.S., Fujii,R., Ishikawa,H. and Kawano,M.M. (1999) Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity. Blood, 94, 3551-3558.
42. Callard,R. and Hodgkin,P. (2007) Modeling T- and B-cell growth and differentiation. Immunol. Rev., 216, 119-129.
43. Barberis,A., Widenhorn,K., Vitelli,L. and Busslinger,M. (1990) A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev., 4, 849-859.
44. Kozmik,Z., Sure,U., Ruedi,D., Busslinger,M. and Aguzzi,A. (1995) Deregulated expression of PAX5 in medulloblastoma. Proc. Natl Acad. Sci. USA, 92, 5709-5713.
45. Stuart,E.T., Haffner,R., Oren,M. and Gruss,P. (1995) Loss of p53 function through PAX-mediated transcriptional repression. EMBO J., 14, 5638-5645.
46. Fitzsimmons,D., Hodsdon,W., Wheat,W., Maira,S.M., Wasylyk,B. and Hagman,J. (1996) Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev., 10, 2198-2211.
47. Oppezzo,P., Dumas,G., Lalanne,A.I., Payelle-Brogard,B., Magnac,C., Pritsch,O., Dighiero,G. and Vuillier,F. (2005) Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells. Blood, 105, 2495-2503.